The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a CAGR of 5.5% from 2022 to 2028.

Increasing Adoption and Outsourcing of Clinical Trials Fuels Europe Clinical Trials Market

Clinical trials are essential for proving if a new treatment or prevention—like a drug, diet, or medical device—is safe and effective. These trials are primarily conducted during drug development. The European Medicine Agency reports that roughly 4,000 clinical trials are authorized annually in the EU, with about 60% coming from the pharmaceutical industry. The growing number of clinical trials for developing diverse effective treatments, driven by the increasing prevalence of chronic diseases, is boosting the clinical trials market.

As clinical trials become more complex, it's crucial to properly execute and oversee operations within research organizations. To avoid errors from improper execution, these organizations are outsourcing clinical trials to develop their products. Clinical Research Organizations (CROs) help successfully implement trials by offering services with high-quality facilities and deep subject matter expertise. CROs have become a backbone of the clinical trial industry due to their efficient and cost-effective operations, benefiting trial sponsors. This focus on cost-effective solutions and reduced errors in CROs during drug development is driving the clinical trials market's growth.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00028989

Europe Clinical Trials Market Overview

The Europe clinical trials market includes the UK, Germany, France, Italy, Spain, and the Rest of Europe. The market in Europe will likely grow during the forecast period due to the rising number of clinical trial activities for new drug development and innovative product launches by companies.

In Germany, cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials. Germany's well-established transport, communication, energy, and public services infrastructure supports clinical research. Plus, the country has a large patient pool and high demand for quality healthcare. The Federal Ministry of Education and Research created a new funding program to establish coordinating centers for clinical trials, fostering academic clinical research. Depending on the product, clinical trials in Germany are approved by either the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute.

Europe Clinical Trials Market Segmentation

Europe Clinical Trials Market By Study Design

Interventional

Observational

Expanded Access

Europe Clinical Trials Market By Phase

Phase I

Phase II

Phase III

Phase IV

Europe Clinical Trials Market By Indication

Autoimmune/Inflammation

Pain Management

Oncology

CNS Condition

Diabetes

Obesity

Cardiovascular

Europe Clinical Trials Market Regions and Countries Covered       

Europe

UK

Germany

France

Russia

Italy

Rest of Europe

Europe Clinical Trials Market leaders and key company profiles   

Charles River Laboratories InternationalInc

ICON Plc

IQVIA Holdings Inc

IXICO Plc

Laboratory Corp of America Holdings

Parexel International Corp

SGS SA

Syneos Health Inc

Thermo Fisher Scientific Inc

WuXi AppTec Co Ltd

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications